COAGULATION FACTOR VIII , COAGULATION FACTOR VIIA , COAGULATION FACTOR IX , SAR439774, FACTOR VIII INHIBITOR BYPASSING ACTIVITY , ANTITHROMBIN III
LTE15174
Phase 3 small_molecule active
Quick answer
COAGULATION FACTOR VIII , COAGULATION FACTOR VIIA , COAGULATION FACTOR IX , SAR439774, FACTOR VIII INHIBITOR BYPASSING ACTIVITY , ANTITHROMBIN III for Hemophilia A or Hemophilia B is a Phase 3 program (small_molecule) at Genzyme Europe B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genzyme Europe B.V.
- Indication
- Hemophilia A or Hemophilia B
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active